Evidence map›Paper›PMID 35632749›Full record

ArticleViruses2022

SARS-CoV-2 Lineage A.27: New Data from African Countries and Dynamics in the Context of the COVID-19 Pandemic.

Anissa Chouikha, Adamou Lagare, Kais Ghedira, Amadou Diallo, Richard Njouom, Safietou Sankhe, Fawzi Derrar, Kathleen Victoir, Koussay Dellagi, Henda Triki and 2 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 6 countries.

Anissa ChouikhaLaboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1002, Tunisia.ORCID 0000-0001-5616-0204
Adamou LagareCentre de Recherche Médicale et Sanitaire (CERMES), BP: 10887-634 Bd de la Nation, Niamey YN034, Niger.
Kais GhediraLaboratory of Bioinformatics, Biomathematics and Biostatistics (BIMS), Institut Pasteur de Tunis (IPT), 13, Place Pasteur BP 74, University of Tunis-El Manar, Tunis 1002, Tunisia.ORCID 0000-0002-3387-6493
Amadou DialloInstitut Pasteur Dakar, 36 Avenue Pasteur, Dakar BP 220, Senegal.ORCID 0000-0002-8584-9972
Richard NjouomCentre Pasteur of Cameroon, Centre Pasteur of Cameroon, 451 rue 2005, Yaoundé, Cameroon.
Safietou SankheInstitut Pasteur Dakar, 36 Avenue Pasteur, Dakar BP 220, Senegal.
Fawzi DerrarInstitut Pasteur d'Algérie, 01 Rue du Petite Staouéli, Dély-Brahim, Algiers 16047, Algeria.
Kathleen VictoirInstitut Pasteur, Direction Internationale, Pôle Coopération Scientifique, 25 Rue du Dr Roux, 75015 Paris, France.
Koussay DellagiPasteur Network Association, Institut Pasteur 25 Rue du Dr Roux, 75015 Paris, France.
Henda TrikiLaboratory of Clinical Virology, WHO Reference Laboratory for Poliomyelitis and Measles in the Eastern Mediterranean Region, Pasteur Institute of Tunis, University Tunis El Manar (UTM), Tunis 1002, Tunisia.
Moussa Moise DiagneInstitut Pasteur Dakar, 36 Avenue Pasteur, Dakar BP 220, Senegal.ORCID 0000-0001-5461-5623
REPAIR Consortium
Institut Pasteur de Dakar · SNInstitut Pasteur · FRTunis University · TNCentre de Recherche Médicale et Sanitaire · NECentre Pasteur du Cameroun · CMInstitut Pasteur d'Algérie · DZInstitut Pasteur de Tunis · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is constantly evolving with lineages emerging and others eclipsing. Some lineages have an important epidemiological impact and are known as variants of interest (VOIs), variants under monitoring (VUMs) or variants of concern (VOCs). Lineage A.27 was first defined as a VUM since it holds mutations of concern. Here, we report additional lineage A.27 data and sequences from five African countries and describe the molecular characteristics, and the genetic history of this lineage worldwide. Based on the new sequences investigated, the most recent ancestor (tMRCA) of lineage A.27 was estimated to be from April 2020 from Niger. It then spread to Europe and other parts of the world with a peak observed between February and April 2021. The detection rate of A.27 then decreased with only a few cases reported during summer 2021. The phylogenetic analysis revealed many sub-lineages. Among them, one was defined by the substitution Q677H in the spike (S) gene, one was defined by the substitution D358N in the nucleoprotein (N) gene and one was defined by the substitution A2143V in the ORF1b gene. This work highlights the importance of molecular characterization and the timely submission of sequences to correctly describe the circulation of particular strains in order to be proactive in monitoring the pandemic.

Indexed as

COVID-19SARS-CoV-2Coronavirus Nucleocapsid ProteinsHumansPandemicsPhosphoproteinsPhylogenySpike Glycoprotein, CoronavirusCoronavirus Nucleocapsid Proteinsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2clade 19Blineage A.27phylogenyphylogeographySARS-CoV-2tMRCA

Identifiers

PMID35632749
PMCPMC9144831
OpenAlexW4280491782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.